全文获取类型
收费全文 | 8834篇 |
免费 | 403篇 |
国内免费 | 80篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 251篇 |
妇产科学 | 129篇 |
基础医学 | 941篇 |
口腔科学 | 213篇 |
临床医学 | 520篇 |
内科学 | 2527篇 |
皮肤病学 | 133篇 |
神经病学 | 787篇 |
特种医学 | 390篇 |
外科学 | 1620篇 |
综合类 | 22篇 |
预防医学 | 170篇 |
眼科学 | 103篇 |
药学 | 445篇 |
中国医学 | 17篇 |
肿瘤学 | 999篇 |
出版年
2023年 | 55篇 |
2022年 | 116篇 |
2021年 | 205篇 |
2020年 | 109篇 |
2019年 | 185篇 |
2018年 | 205篇 |
2017年 | 188篇 |
2016年 | 243篇 |
2015年 | 211篇 |
2014年 | 327篇 |
2013年 | 345篇 |
2012年 | 548篇 |
2011年 | 594篇 |
2010年 | 378篇 |
2009年 | 302篇 |
2008年 | 484篇 |
2007年 | 515篇 |
2006年 | 529篇 |
2005年 | 582篇 |
2004年 | 563篇 |
2003年 | 494篇 |
2002年 | 508篇 |
2001年 | 142篇 |
2000年 | 147篇 |
1999年 | 165篇 |
1998年 | 106篇 |
1997年 | 82篇 |
1996年 | 71篇 |
1995年 | 63篇 |
1994年 | 60篇 |
1993年 | 49篇 |
1992年 | 71篇 |
1991年 | 65篇 |
1990年 | 73篇 |
1989年 | 81篇 |
1988年 | 56篇 |
1987年 | 43篇 |
1986年 | 36篇 |
1985年 | 30篇 |
1984年 | 27篇 |
1983年 | 23篇 |
1982年 | 30篇 |
1981年 | 21篇 |
1980年 | 16篇 |
1979年 | 22篇 |
1978年 | 16篇 |
1977年 | 25篇 |
1976年 | 15篇 |
1974年 | 14篇 |
1967年 | 15篇 |
排序方式: 共有9317条查询结果,搜索用时 15 毫秒
991.
Down syndrome candidate region 1,a downstream target of VEGF, participates in endothelial cell migration and angiogenesis 总被引:3,自引:0,他引:3
Vascular endothelial growth factor (VEGF) is a principal stimulator of angiogenesis. However, the downstream targets of VEGF in endothelial cells (ECs) are not entirely clarified. Survey of downstream targets of VEGF in human ECs identified a number of genes, including Down syndrome candidate region 1 (DSCR1). Here, we confirmed the inducible expression of DSCR1 in ECs by Northern and Western blottings. Moreover, VEGF-stimulated induction of DSCR1 was blocked by anti-VEGF receptor-2 monoclonal antibody (mAb), or the specific calcineurin inhibitors cyclosporin A and FK506. The expression of DSCR1 in ECs of neovessels was further shown by immunohistochemical analysis. We therefore examined whether DSCR1 played any roles in angiogenesis. The specific downregulation of DSCR1 expression by antisense oligonucleotide (AS-ODN) inhibited VEGF-stimulated migration of ECs as well as angiogenesis in vivo. AS-ODN inhibited the spreading of ECs on vitronectin, as well as on the immobilized anti-alphavbeta3 mAb, but not on anti-alphavbeta5 mAb. Moreover, AS-ODN inhibited tyrosine phosphorylation of focal adhesion kinase when ECs were plated on a vitronectin-coated dish. Immunoprecipitation followed by Western blotting showed the coimmunoprecipitation of DSCR1 and integrin alphavbeta3. These results suggest that DSCR1 is involved in angiogenesis by regulating adhesion and migration of ECs via the interaction with integrin alphavbeta3. 相似文献
992.
Miyazaki H Noma K Date T Kobayashi A Koga A Kuno M Takeda S Iwano K Seki S Inada K Matsuo S Miyanaga S Abe K Yamane T Sugimoto K Mochizuki S 《Journal of cardiology》2005,45(6):239-246
OBJECTIVES: Atrial septal pacing via a trans-septal breakthrough site within the right atrial septum can shorten global atrial activation time, resulting in significant reduction of recurrence of atrial fibrillation events. This study examined whether this pacing method will lead to resynchronization of atrial contraction and its benefit on hemodynamic function can be maintained for 24 months. METHODS: Thirty patients with atrial fibrillation and delayed atrial conduction were enrolled (17 males, 13 females, mean age 73 +/- 7 years). Trans-septal breakthrough site within the right atrial septum was identified through pacing from the dorsal left atrium. Continuous atrial septal pacing at the trans-septal breakthrough site was performed for 24 months. Time difference (TD) between right and left atrial contractions was measured during atrial septal pacing and sinus rhythm by pulse Doppler echocardiography of the trans-tricuspid (P-At) and mitral (P-Am) blood flows (TD = P-Am - P-At). RESULTS: The atrial lead was screwed near the fossa ovalis in 29 of 30 patients. Atrial septal pacing yielded significantly shorter P wave duration (101.9 +/- 10.4 vs 139.6 +/- 14.7 msec, p < 0.001), leading to significant reduction of TD in atrial contraction (-8.8 +/- 10.0 vs 29.8 +/- 13.6 msec, p < 0.001)as compared to sinus rhythm. Both shorter P wave duration and reduced TD during atrial septal pacing remained statistically significant during the follow-up period as compared to sinus rhythm. Both left atrial diameter and A to E ratio of filling waves at mitral valve were significantly decreased at 12 months and remained decreased at 24 months. CONCLUSIONS: Atrial septal pacing at the trans-septal breakthrough site can resynchronize atrial contraction and results in improved hemodynamic effects during 24 months of follow-up. 相似文献
993.
Yamashita M Otsuka F Mukai T Otani H Inagaki K Miyoshi T Goto J Yamamura M Makino H 《The Journal of endocrinology》2008,196(3):601-613
Recent studies have shown that the mevalonate pathway plays an important role in skeletal metabolism. Statins stimulate bone morphogenetic proteins-2 (BMP-2) production in osteoblasts, implicating a possible beneficial role for statins in promoting anabolic effects on bone. Here, we investigated the effects of a lipophilic simvastatin on osteoblast differentiation using mouse myoblast C2C12 cells, in the presence of tumor necrosis factor-alpha (TNF-alpha), an inflammatory cytokine that inhibits osteogenesis. The addition of TNF-alpha to C2C12 cells suppressed the BMP-2-induced expression of key osteoblastic markers including Runx2 and alkaline phosphatase (ALP) activity. Simvastatin had no independent effects on Runx2 and alkaline phosphatase activity; however, it reversed the suppressive effects of TNF-alpha. The ability of simvastatin to reverse TNF-alpha inhibition of BMP-induced Smad1,5,8 phosphorylation and Id-1 promoter activity suggests the involvement of Smad signaling pathway in simvastatin action. In addition, cDNA array analysis revealed that simvastatin increased expression levels of Smads in C2C12 cells exposed to TNF-alpha that also activated mitogen-activated protein kinase (MAPK) signaling pathways, including extracellular signal-regulated kinase 1/2 (ERK1/2), P38, and stress-activated protein kinase/c-Jun NH2-terminal kinase (SAPK/JNK). Simvastatin potently suppressed TNF-alpha-induced phosphorylation of ERK1/2 and SAPK/JNK by inhibiting TNF-alpha-induced membrane localization of Ras and RhoA. Farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP) reversed the simvastatin effects on TNF-alpha-induced activation of Ras/Rho/MAPK pathways. FPP and GGPP also restored the simvastatin effects on TNF-alpha-induced suppression of Runx2 and ALP activity. In addition, simvastatin decreased the expression levels of TNF type-1 and -2 receptor mRNAs. Collectively, simvastatin supports BMP-induced osteoblast differentiation through antagonizing TNF-alpha-to-Ras/Rho/MAPK pathway and augmenting BMP-Smad signaling, suggesting a potential usage of statins to ameliorate inflammatory bone damage. 相似文献
994.
995.
Kobayashi M Watanabe K Ishigami M Murase K Ito H Ukai K Yano M Takagi K Hattori M Kakumu S Yoshioka K 《The American journal of gastroenterology》2002,97(4):988-998
OBJECTIVES: The interferon sensitivity-determining region (ISDR) in nonstructural region 5A (NS5A) of hepatitis C virus genotype 1b has been reported to correlate with response to interferon therapy and viral load. Recently the correlation between NS5A and response to interferon in genotype 2a was also reported. We examined the region of genotypes 2a and 2b corresponding to the ISDR of genotype lb to elucidate its correlation with response to interferon and viral load. METHODS: The sequences of amino acid positions 2213-2248 in NS5A were determined in 39 patients with genotype 2a and 12 patients with genotype 2b. RESULTS: In the patients infected with genotype 2a, the number of amino acid substitutions in the ISDR-corresponding region compared with the consensus sequence of genotype 2a was significantly correlated with viral load (p = -0.541, p < 0.001) and with response to interferon therapy (p < 0.05); 83% of the patients with three or more substitutions obtained sustained responses, whereas only 44% of those with less than three substitutions obtained sustained responses. Multivariate analysis confirmed that the number of substitutions in the ISDR-corresponding region of genotype 2a was one of the independent predictors of response to interferon therapy (discriminant coefficient = 1.35, p < 0.001). CONCLUSIONS: Substitutions in the ISDR-corresponding region in NS5A of hepatitis C virus genotype 2a was confirmed to correlate to viral load and response to interferon therapy. In genotype 2b, further work must be considered because of the small number of patients studied. 相似文献
996.
Inoue H Kurosawa H Nonoyama S Imai K Kumazaki H Matsunaga T Sato Y Sugita K Eguchi M 《British journal of haematology》2002,118(4):1163-1165
We report X-linked thrombocytopenia (XLT) in a 6-year-old girl with petechiae and thrombocytopenia from the age of 3 months. Her 2-year-old brother was also diagnosed with XLT. The Wiskott-Aldrich syndrome protein (WASP) gene was detected as a replacement of +5th G to Aon intron 6 using sequence analysis, and the WASP expression levels in this patient were one-third those of a healthy control. The X-inactivation analysis of the patients lymphocytes showed a random pattern of X-chromosome inactivation. To our knowledge, this is the first confirmed report of XLT in a female. 相似文献
997.
998.
Expression of the inhibitor of apoptosis (IAP) family members in human neutrophils: up-regulation of cIAP2 by granulocyte colony-stimulating factor and overexpression of cIAP2 in chronic neutrophilic leukemia 总被引:4,自引:1,他引:4
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Hasegawa T Suzuki K Sakamoto C Ohta K Nishiki S Hino M Tatsumi N Kitagawa S 《Blood》2003,101(3):1164-1171
999.
FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy 总被引:12,自引:4,他引:12
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Taketani T Taki T Sugita K Furuichi Y Ishii E Hanada R Tsuchida M Sugita K Ida K Hayashi Y 《Blood》2004,103(3):1085-1088
1000.
Kenichi Fukushima Yoshio Kobayashi Tomonobu Okuno Yoshitake Nakamura Masayoshi Sakakibara Takashi Nakayama Nakabumi Kuroda Akira Miyazaki Youichi Shimizu Issei Komuro 《Circulation journal》2007,71(4):617-619
BACKGROUND: Because of its side-effects, long-term administration of ticlopidine limits the use of the sirolimus-eluting stent (SES) in Japan. METHODS AND RESULTS: Side-effects of ticlopidine occurred in 41 (9.3%) of 440 patients who underwent SES implantation. The majority were liver dysfunction (4.5%) and rash (3.6%). One patient died from severe liver dysfunction. Neutropenia occurred in 3 patients (0.7%). It is remarkable that 28% of side-effects occurred >8 weeks after the initiation of ticlopidine. CONCLUSIONS: Ticlopidine has a relative high rate of side-effects. Clopidogrel should be approved for prevention of stent thrombosis as soon as possible. 相似文献